Related Experiment Video
Updated: Jun 30, 2025

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells
Published on: September 1, 2010
RBBP6 maintains glioblastoma stem cells through CPSF3-dependent alternative polyadenylation
Peng Lin1,2,3, Wenyan Chen4, Zhilin Long2,3
1College of Life Sciences, Zhejiang University, Hangzhou, Zhejiang, China.
Abstract:
Glioblastoma is one of the most lethal malignant cancers, displaying striking intratumor heterogeneity, with glioblastoma stem cells (GSCs) contributing to tumorigenesis and therapeutic resistance. Pharmacologic modulators of ubiquitin ligases and deubiquitinases are under development for cancer and other diseases. Here, we performed parallel in vitro and in vivo CRISPR/Cas9 knockout screens targeting human ubiquitin E3 ligases and deubiquitinases, revealing the E3 ligase RBBP6 as an essential factor for GSC maintenance. Targeting RBBP6 inhibited GSC proliferation and tumor initiation. Mechanistically, RBBP6 mediated K63-linked ubiquitination of Cleavage and Polyadenylation Specific Factor 3 (CPSF3), which stabilized CPSF3 to regulate alternative polyadenylation events. RBBP6 depletion induced shortening of the 3'UTRs of MYC competing-endogenous RNAs to release miR-590-3p from shortened UTRs, thereby decreasing MYC expression. Targeting CPSF3 with a small molecular inhibitor (JTE-607) reduces GSC viability and inhibits in vivo tumor growth. Collectively, RBBP6 maintains high MYC expression in GSCs through regulation of CPSF3-dependent alternative polyadenylation, providing a potential therapeutic paradigm for glioblastoma.
Insights
RBBP6 is crucial for glioblastoma stem cell survival and tumor growth. Targeting RBBP6 or CPSF3 inhibits glioblastoma, offering new therapeutic strategies for this lethal brain cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Glioblastoma is a highly lethal brain cancer characterized by significant intratumor heterogeneity.
- Glioblastoma stem cells (GSCs) play a critical role in glioblastoma development and resistance to therapy.
- Ubiquitin ligases and deubiquitinases are emerging therapeutic targets in cancer.
Purpose of the Study:
- To identify essential ubiquitinating enzymes for glioblastoma stem cell maintenance using large-scale genetic screens.
- To elucidate the molecular mechanisms by which identified targets regulate GSC function.
- To evaluate the therapeutic potential of targeting these mechanisms in glioblastoma.
Main Methods:
- Conducted parallel in vitro and in vivo CRISPR/Cas9 knockout screens targeting human ubiquitin E3 ligases and deubiquitinases.
- Investigated the role of the identified E3 ligase, RBBP6, in GSC proliferation and tumor initiation.
- Analyzed the mechanism involving RBBP6, Cleavage and Polyadenylation Specific Factor 3 (CPSF3) ubiquitination, and alternative polyadenylation.
- Assessed the impact of targeting RBBP6 and CPSF3 (using JTE-607) on GSC viability and tumor growth.
Main Results:
- RBBP6 was identified as an essential E3 ligase for glioblastoma stem cell maintenance.
- Targeting RBBP6 significantly inhibited GSC proliferation and tumor initiation.
- RBBP6 stabilizes CPSF3 through K63-linked ubiquitination, regulating alternative polyadenylation.
- RBBP6 depletion leads to shortened 3'UTRs of MYC competing-endogenous RNAs, decreasing MYC expression via miR-590-3p release.
- Inhibition of CPSF3 with JTE-607 reduced GSC viability and inhibited tumor growth in vivo.
Conclusions:
- RBBP6 is a key regulator of glioblastoma stem cell maintenance by controlling MYC expression through CPSF3-dependent alternative polyadenylation.
- Targeting RBBP6 or CPSF3 presents a promising therapeutic strategy for glioblastoma treatment.
More Related Videos
12:25Optimization of High Grade Glioma Cell Culture from Surgical Specimens for Use in Clinically Relevant Animal Models and 3D Immunochemistry
Published on: January 7, 2014
10:28Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells
Published on: January 10, 2018
Related Concept Videos
Abnormal Proliferation
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Negative Regulator Molecules
The Ras Gene
Ras is a...